[1]
M. H. Gul, A. B. Wardak, and A. Waheed, “Navigating a paradigm shift; food and drug administration approved Tarlatamab-dlle redefining the landscape of small cell lung cancer therapy”, Int J Sci Rep, vol. 10, no. 8, pp. 303–304, Jul. 2024.